If you could vote on Brexit now which option would you choose?
   

Medical journal editorial refutes WHO finding on Gilead's remdesivir for COVID-19


An editorial in the influential New England Journal of Medicine cites problems with a World Health Organization (WHO) study that found Gilead Sciences Inc’s antiviral remdesivir failed to improve COVID-19 survival, and said it does not refute trials that demonstrated benefits of the drug in treating the illness. The editorial, by David Harrington at the Harvard T.H. Chan School of Public Health, infectious disease specialist Dr. Lindsey Baden and Brown University biostatistician Joseph Hogan, was published on Wednesday along with the WHO study. They noted that the trial called Solidarity, which looked at four drugs, was conducted in 30 countries ranging from Switzerland and Germany to Iran and Kenya, leading to inconsistencies in the data collected.

Reuters - December 2, 2020

View the full story here: https://uk.reuters.com/article/uk-health-coronavirus-gilead-remdesivir/medical-journal-editorial-refutes-who-finding-on-gileads-remdesivir-for-covid-19-idUKKBN28C3EX